In this special episode of Skin Anarchy’s Lessons in Longevity series, Dr. Ekta Yadav sits down with visionary beauty executive and entrepreneur Melisse Shaban to explore the evolving intersection of skincare, cellular biology, and longevity science.
Shaban’s career spans decades in the beauty industry — from standing behind the counter at Revlon in Macy’s Herald Square during the golden era of celebrity-driven beauty, to leading transformative brands like Aveda and The Body Shop, to founding science-led ventures such as Virtue Labs and pioneering cellular energy-focused skincare through Aramore.
But what makes this conversation different is not nostalgia — it’s perspective.
Redefining Beauty Through the Lens of Wellness
Shaban reflects on how beauty was historically defined — often by male executives, often centered around youth — and how that narrative is finally being dismantled. Today, she argues, beauty is being reimagined through the prism of wellness, vitality, and longevity.
Fifty is no longer considered “old.” Aging is no longer the enemy. And skincare is no longer just about surface-level moisturization.
Instead, we are entering a transformative era where biology, cellular performance, and recovery are shaping the conversation.
From “Hope in a Jar” to Real Skin Biology
One of the central themes of the episode is the industry’s evolution away from marketing-driven promises toward science-backed performance.
Shaban shares her experience commercializing technologies born not in cosmetic labs — but in oncology, regenerative medicine, and peptide research. Many of the most meaningful innovations in skincare, she explains, begin in academic laboratories where researchers are solving entirely different problems. Skincare applications often emerge as a byproduct of real medical breakthroughs.
The question becomes: are brands truly rooted in science, or simply leveraging credentials?
This distinction matters — especially in an era where clinical data, transparency, and ingredient validation should be non-negotiable.
The NAD Conversation: Cellular Energy Comes to Skincare
At the heart of the discussion is NAD (nicotinamide adenine dinucleotide), a molecule essential to cellular energy production and mitochondrial function. While NAD has long been understood within scientific and medical communities, it has only recently entered mainstream wellness and skincare conversations.
The challenge? NAD itself is too large to penetrate skin cells effectively.
Shaban explains how Aramore approaches this differently — not by delivering NAD directly, but by stimulating the body’s own NAD production through lipid-compatible pathways the skin can recognize and absorb. Rather than layering surface hydration, the focus shifts to cellular metabolism and energy performance.
Because as Dr. Yadav emphasizes, skin is not just a barrier — it is a metabolically active organ. And aging begins at the cellular level long before it appears on the surface.
Longevity Is Daily Maintenance — Not Damage Control
This episode reframes skincare as daily cellular nourishment rather than reactive correction. Instead of exfoliating aggressively or chasing trend-driven actives, the future lies in steady metabolic support.
Shaban also expands the longevity conversation beyond the face: hair preservation, skin elasticity, muscle strength, recovery protocols, and even the integration of sauna and cold therapy into lifestyle routines.
Longevity is not about one product. It is about systemic resilience.
The Responsibility of Science in a Noisy Industry
Perhaps the most candid portion of the episode centers around accountability.
Shaban and Dr. Yadav discuss the growing problem of perception-based marketing claims, influencer misinformation, and the dilution of scientific language. Terms like “clinical,” “medical-grade,” and “science-backed” have become ubiquitous — but often lack rigor.
Real clinical trials. Transparent data. Mechanistic plausibility.
These are the standards that should define modern beauty.
As Shaban notes, consumers are more educated than ever. The GLP-1 conversation, metabolic health awareness, and longevity research have raised expectations. The industry must meet that moment — or risk losing credibility.
Where We’re Headed
The longevity era is not about fear of aging. It is about cellular performance, recovery, and maintaining vitality over time.
For Shaban, the future of skincare will be disciplined — fewer SKUs, deeper science, greater transparency. Products will complement existing routines rather than replace them. Intervention and recovery will coexist. And brands that cannot substantiate their claims will be forced to evolve.
As Dr. Yadav puts it: this is the moment where skincare finally begins to think like physiology.
Listen to the full episode of Skin Anarchy to hear Melisse Shaban share her perspective on cellular energy, real clinical science, and why the future of beauty belongs to longevity-driven innovation.